NCT05966753Completed
Describing Patient With DME, Their Patient Journey and Disease Progression
Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)
Source: ClinicalTrials.gov · Last updated 19 Dec 2024
Brief summary (registry, in English)
This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 221004 (actual)
- First submitted
- 21 Jul 2023
- Start date
- 3 Aug 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Boehringer Ingelheim
- Diseases
- Diabetic eye disease
- NCT number
- NCT05966753
What you commit to
- Study type: Observational
- Participants enrolled: 221004
- From 3 Aug 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients without the information of laterality will be excluded.
Who the study is looking for
- All patients ≥18 years, with a DME diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CorEvitas HQ Coordinator of this site? Confirm its status | Waltham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.